Safety and efficacy of intravenous adenosine for pharmacologic stress testing in children with aortic valve disease or Kawasaki disease.

Abstract

This study assessed the safety and efficacy of intravenous adenosine used as a coronary vasodilator in 18 pediatric patients with aortic valve disease or Kawasaki disease. Adenosine infusion effectively produced coronary vasodilation and was well tolerated.

• Authors: A S Prabhu, T P Singh, W R Morrow, O Muzik, M F Di Carli
• Journal: The American journal of cardiology (Am J Cardiol) Vol. 83 Issue 2 Pg. 284-6, A6 (Jan 15 1999) ISSN: 0002-9149 [Print] United States
• PMID: 10073840 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Vasodilator Agents
• Adenosine

Topics

• Adenosine (adverse effects)
• Adolescent
• Adult
• Aortic Valve Insufficiency (physiopathology)
• Child
• Coronary Vessels (drug effects)
• Exercise Test (methods)
• Female
• Hemodynamics (drug effects)
• Humans
• Infusions, Intravenous
• Male
• Mucocutaneous Lymph Node Syndrome (physiopathology)
• Perfusion
• Tomography, Emission-Computed
• Vasodilation (drug effects)
• Vasodilator Agents (adverse effects)